Here are the DEF 14A proxy statements from OneMedNet Corp Warrant (ONMDW) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow ONMDW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ONMDW filings page.
OneMedNet Corporation (ONMD) is asking stockholders at its fully virtual 2026 annual meeting on September 18, 2026 to approve several key items. Stockholders will vote to elect three Class III directors (Kenneth Alleyne, Sherry Coonse McCraw, and Jeffrey Yu) to three-year terms, ratify WithumSmith+Brown, PC as independent auditor for 2026, approve an amendment and restatement of the 2022 Equity Incentive Plan adding 1,000,000 shares to the share reserve, and authorize the Board to implement a reverse stock split at a ratio between 1-for-5 and 1-for-20.
As of August 11, 2026, OneMedNet had 59,286,450 shares of common stock outstanding and was out of compliance with Nasdaq’s $1.00 minimum bid price requirement, with a cure period running until October 12, 2026. The Board states that a reverse split may be used to help regain compliance and maintain the Nasdaq Capital Market listing. The equity plan currently has 826,417 shares available and 4,217,303 shares subject to outstanding RSUs, and the company estimates the newly requested plan shares equal about 1.7% of outstanding stock.